Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7265 - 7272 of 12084 results

The Uncertain Future of the 340B Drug Discount Program
March 14, 2017| Blog| Viewpoint

Provider Payments Under a Medicaid Per Capita Cap
March 14, 2017| Blog| Viewpoint

Cloudbleed: Three Risk Management Lessons Learned
March 13, 2017| Blog| Viewpoint

Insurtech: Adapting to a new way of looking at insurance
March 13, 2017| News

Voices of the Industry: Advice and Insights from Legal Experts
March 13, 2017| News

When Hiding Assets Doesn’t Work: How Mintz Recovered $20M for Cheated Client
March 13, 2017| News

The Return of Mintz March Madness
March 13, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
IP Strategist Daniel Brownstone Joins Mintz in New York
July 30, 2025
Daniel Brownstone has joined Mintz as a Member in the firm’s Intellectual Property Division, adding depth to the firm’s IP Prosecution Practice and contributing to its continued growth in the market. He will be based in the firm’s New York office.
Intelligize referenced a recent article by Mintz Member Jacob Hupart in its coverage of the ongoing court challenges to the Securities and Exchange Commission’s climate disclosure rule. Jacob’s piece examines the Eighth Circuit’s decision to hold litigation over the rule “in abeyance.”
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
